nabiximols: Clinical Trials

227 trials of nabiximols, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

134 completed, 22 recruiting, 17 unknown, 17 withdrawn. 81 Phase 1, 76 Phase 2, 44 Phase 3, 28 Not applicable, 10 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 181Completed 47, Recruiting 8, Terminated 6, Active not recruiting 5, Not yet recruiting 5, Unknown 5, Withdrawn 5
Phase 276Completed 32, Withdrawn 10, Unknown 9, Terminated 7, Recruiting 6, Active not recruiting 5, Not yet recruiting 4, Suspended 3
Phase 344Completed 35, Withdrawn 4, Terminated 2, Unknown 2, Recruiting 1
Not applicable28Completed 19, Recruiting 6, Not yet recruiting 1, Terminated 1, Unknown 1
Early Phase 110Completed 6, Not yet recruiting 2, Terminated 1, Unknown 1
Phase 43Completed 1, Unknown 1, Withdrawn 1

Follow nabiximols: new trials by email Literature Review of nabiximols trials Research Report on nabiximols

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioral Pharmacology of THC and Beta-Myrcene
Placebo, THC, Beta-Myrcene - Cannabis Use
Phase 1Not yet recruitingJohns Hopkins University322027-07-012026-07-31
Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study
Cannabis oil, Placebo - Pruritus
Phase 2Not yet recruitingUniversity Hospital, Brest2182027-01-012026-06-12
A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
Nabiximols, Placebo - NMO Spectrum Disorder, Spasticity, Muscle
Phase 2WithdrawnMichael, Levy M.D.,Ph.D.2026-12-312025-07-16
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
Cannabis - Cannabis Use, Impaired Driving
Phase 1Not yet recruitingJohns Hopkins University402026-12-012026-10-16
Cannabis Effects on Opioid Self-Administration
Cannabis, Placebo Cannabis, Intranasal Opioid Agonist - Opioid Use Disorder, Cannabis Use
Phase 1Not yet recruitingShanna Babalonis, PhD302026-11-302026-10-14
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis (THC), Tobacco Cigarette - Cannabis Use, Tobacco
Early Phase 1Not yet recruitingHannah Harris122026-11-012026-10-06
Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream
Biospecimen Collection, Cannabis sativa Extract, Nicotine - Cannabis Dependence
Early Phase 1Not yet recruitingRoswell Park Cancer Institute602026-10-152026-09-25
Repeated Administration of Cannabis Varying in THC and CBD
Cannabis - Cannabis
Phase 2SuspendedNew York State Psychiatric Institute1002026-10-012026-09-01
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
Cannabis, 0 mg THC (placebo) - Cannabis Intoxication
Phase 1RecruitingJohns Hopkins University702026-09-152026-09-18
A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
Cannabis, placebo - Cannabis
Phase 1 / Phase 2Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)802026-09-012025-12-22
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder
Phase 1 / Phase 2Not yet recruitingLeslie Lundahl2802026-09-012026-08-26
Cannabis for Obesity Trial
Cannabis, Placebo - Obesity
Phase 2RecruitingJoshua A. Lile, Ph.D.402026-08-052026-08-07
Cannabis Vs Opioids Pain Management Objective Testing Comparisons
Monochromatic Infrared Photo Energy (MIRE), Transcutaneous Electrical Nerve Stimulation, Opioids - Chronic Pain, Circulatory Disorders
Not applicableNot yet recruitingAmerican Association of Sensory Electrodiagnostic Medicine10002026-06-032025-12-29
Pregnenolone as a Treatment for Cannabis Intoxication
Cannabis, Pregnenolone 250 mg, Pregnenolone 500 mg - Cannabis Intoxication
Phase 2RecruitingJohns Hopkins University202026-04-242026-09-29
Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden
Cannabis Extract Oil, Placebo - Advanced Malignant Solid Tumor
Phase 2Not yet recruitingNational Cancer Institute, Naples1562026-04-012026-03-10
In-Vehicle Real-Time Cannabis Influenced Driving Detection
Cannabis (THC) - Driving Under the Influence, Cannabis-impaired Driving
Not applicableCompletedUniversity of Bern452026-01-052026-07-20
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 4
Cannabis (smoked flower) - Cannabis, Memory
RecruitingL. Cinnamon Bidwell642025-12-102026-07-01
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
Placebo, THC, CBD 20 mg - Abuse, Drug, Pain
Phase 1RecruitingUniversity of California, Los Angeles302025-11-052025-12-17
Oral and Topical Phytocannabinoids for Psoriasis
Oral Cannabis Extract, Topical cannabis cream - Psoriasis Vulgaris
Phase 2Active not recruitingFederal University of Latin American Integration372025-11-012026-09-24
THC Titration of High-Potency Cannabis Concentrates
Cannabis (30% THC Concentrate), Cannabis (60% THC Concentrate), Cannabis (90% THC Concentrate) - THC
Not applicableRecruitingCentre for Addiction and Mental Health482025-10-012026-06-11

Showing 20 of 227. Sign in to see all of them.

Conditions studied

Marijuana Abuse (109)  ·  Pain (30)  ·  Multiple Sclerosis (23)  ·  Muscle Spasticity (17)  ·  Neuralgia (10)  ·  Neoplasms (9)  ·  Substance-Related Disorders (8)  ·  Driving Under the Influence (7)  ·  Anxiety Disorders (5)  ·  Cancer Pain (5)  ·  Chronic Pain (5)  ·  Peripheral Nervous System Diseases (5)  ·  Alcohol Drinking (4)  ·  Alcoholic Intoxication (4)  ·  Marijuana Smoking (4)

Sponsors

Jazz Pharmaceuticals (37)  ·  Johns Hopkins University (15)  ·  New York State Psychiatric Institute (14)  ·  Centre for Addiction and Mental Health (10)  ·  University of California, San Diego (9)  ·  GW Pharmaceuticals Ltd (7)  ·  Federal University of Latin American Integration (5)  ·  Yale University (5)  ·  Hadassah Medical Organization (4)  ·  Shanna Babalonis, PhD (4)  ·  University of California, San Francisco (4)  ·  Battelle Memorial Institute (3)  ·  Center for Medicinal Cannabis Research (3)  ·  Radboud University Medical Center (3)  ·  TO Pharmaceuticals (3)

Countries

United States (104)  ·  United Kingdom (37)  ·  Canada (29)  ·  Israel (21)  ·  Czechia (9)  ·  Italy (8)  ·  Poland (8)  ·  Brazil (7)  ·  Germany (7)  ·  Romania (6)  ·  Spain (6)  ·  France (5)  ·  Bulgaria (4)  ·  Hungary (4)  ·  India (4)

Top investigators

Ryan Vandrey, PhD (6)  ·  Margaret Haney, Ph.D. (4)  ·  Shanna Babalonis, PhD (3)  ·  Tory Spindle, PhD (3)  ·  Barbara Hoggart, MBBS, FRCA (2)  ·  Bernard Le Foll, MD, PhD (2)  ·  Didier Jutras-Aswad, MD,MS (2)  ·  Donald I Abrams, M.D. (2)  ·  Godfrey Pearlson, M.D (2)  ·  Jeremy R Johnson, MB ChB (2)  ·  Marcel Olde Rikkert, prof. dr. (2)  ·  Nathaniel M Schuster, MD (2)  ·  Thomas D Marcotte, PhD (2)  ·  Ziva Cooper, PhD (2)  ·  A. Eden Evins, MD (1)

Results publications

PMID 25475413, PMID 34532852, PMID 15327042, PMID 19896326, PMID 23141881, PMID 26144593, PMID 26257143, PMID 28576350, PMID 31527291, PMID 33623076, PMID 34173005, PMID 12465055, PMID 12648025, PMID 15094417, PMID 15561385, PMID 16186518, PMID 16214880, PMID 16317825, PMID 17063973, PMID 17086911, PMID 17355549, PMID 17429350, PMID 17566383, PMID 17916224, PMID 17997224, PMID 18546344, PMID 18728826, PMID 19587829, PMID 19883531, PMID 20076976, PMID 20307378, PMID 20829244, PMID 21049267, PMID 21362108, PMID 21671456, PMID 21878454, PMID 21953990, PMID 22076835, PMID 22483680, PMID 22741619, PMID 22878432, PMID 23052407, PMID 23179176, PMID 23180178, PMID 23742737, PMID 23750331, PMID 24151639, PMID 24420962, PMID 24778283, PMID 25649017

NIH funding

2009 (4), R01DA052431 (3), 2014 (2), 2019 (2), P50DA009236 (2), R01DA043475 (2), R01DA045700 (2), R01DA052295 (2), 2016 (1), 2025 (1), P20GM130414 (1), R01DA013196 (1), R01DA019239 (1), R01DA026799 (1), R01DA034699 (1)